FOXO4-DRI – 10mg

FOXO4‑DRI is a synthetic peptide studied for its senolytic properties, meaning its ability to selectively target and eliminate senescent cells—aging, non‑dividing cells that contribute to inflammation and tissue decline. It works by disrupting the interaction between the FOXO4 protein and p53, triggering programmed cell death (apoptosis) in senescent cells while sparing healthy, functioning cells. This mechanism makes FOXO4‑DRI a key focus in research exploring cellular rejuvenation, healthy aging, and tissue regeneration.

For research purposes only. Not intended for human or animal use.